At IDWeek 2026, IDSA and HIVMA leaders and clinician advocates outline how stories, relationships, and bipartisan outreach shape ID and HIV policy.
|Articles|July 27, 2012
Healthcare fight far from over for NFIB
Advertisement
No one fought harder against the health-care reform law than the National Federation of Independent Business, which led the legal charge against the divisive legislation all the way to the Supreme Court. Now, with the law upheld and the political spotlight turning back to tax relief and spending cuts, we wondered where the small business group would shift its attention and resources.
Read the full story:
Source: The Washington Post
Advertisement
Related to this article
As CKCC nears its sunset, kidney care leaders urge CMS to preserve a dedicated, nephrologist-led accountable care model for advanced kidney disease.
Jennifer Flythe, MD, MPH, discusses individualizing dialysis volume management and why guideline-directed therapy use lags in advanced CKD.
At IDWeek 2026, Atul Gawande, MD, MPH, said USAID cuts are costing lives but that the field is "not back at square one."
Oncologists weighted how to choose, manage, and deliver new therapeutics beyond major academic centers.
Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.
Infant flu protection from maternal vaccination varied by timing, while pediatric vaccination fell to 49.4%, experts report at IDWeek 2026.
Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates.
Advertisement
Advertisement
Trending on AJMC
1
Nephrologists Weigh Wins, Losses From 5 Years of Value-Based Kidney Care
2
Povetacicept Cuts Proteinuria by 52% in IgA Nephropathy at Week 36
3
Merck, Moderna Cancer Vaccine Cuts Melanoma Recurrence Risk by 42%
4
Dialysis Access, Church CKD Screening Address Kidney Care Inequities
5